New Treatments for Childhood Cancers
Pediatric Malignancies Program
This program at UCSF brings together experts to find and develop better, gentler treatments for children with various cancers.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11099778 on NIH RePORTER |
What this research studies
Our program focuses on understanding childhood cancers, including leukemias, brain tumors, and sarcomas, which often start from early developmental tissues. We aim to discover new ways to target these cancers and move promising new therapies into clinical care for children. By connecting basic science with patient care, we hope to create more effective treatments with fewer side effects. We also work to understand how cancer is linked to normal human development.
Who could benefit from this research
Good fit: This program is designed to benefit children, typically aged 0-11 years, who are diagnosed with various pediatric cancers, including leukemias, brain tumors, and sarcomas.
Not a fit: Patients who are adults or have cancer types not typically seen in children may not directly benefit from the specific research focus of this program.
Why it matters
Potential benefit: If successful, this program could lead to new, more effective, and less toxic treatment options for children facing various types of cancer.
How similar studies have performed: Cancer center support grants are a well-established mechanism to foster collaborative research, and similar programs have historically led to significant advancements in cancer treatment.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Sweet-Cordero, Eric Alejandro — University of California, San Francisco
- Study coordinator: Sweet-Cordero, Eric Alejandro
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.